Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023GlobeNewsWire • 02/08/23
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/EmphysemaBusiness Wire • 12/14/22
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/EmphysemaBusiness Wire • 11/30/22
Earnings Preview: Pulmonx Corporation (LUNG) Q3 Earnings Expected to DeclineZacks Investment Research • 10/27/22
3 Medical Info System Stocks to Gain on Rising Demand for Digital HealthZacks Investment Research • 10/14/22
Down 27.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Pulmonx Corporation (LUNG)Zacks Investment Research • 10/13/22
ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/EmphysemaBusiness Wire • 09/09/22
CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/EmphysemaBusiness Wire • 09/04/22
Wall Street Analysts Predict a 79% Upside in Pulmonx Corporation (LUNG): Here's What You Should KnowZacks Investment Research • 08/03/22
Pulmonx Corporation (LUNG) CEO Glen French on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
Can Pulmonx Corporation (LUNG) Climb 117% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 07/18/22
Pulmonx Corporation (LUNG) CEO Glendon French on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
Pulmonx to Present at the Bank of America Securities 2022 Healthcare ConferenceGlobeNewsWire • 04/26/22